309 related articles for article (PubMed ID: 16393287)
1. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
[TBL] [Abstract][Full Text] [Related]
2. Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.
Ryan MC; Desmond PV; Slavin JL; Congiu M
J Viral Hepat; 2011 Jan; 18(1):53-60. PubMed ID: 20196803
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
Yeon JE; Choi KM; Baik SH; Kim KO; Lim HJ; Park KH; Kim JY; Park JJ; Kim JS; Bak YT; Byun KS; Lee CH
J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
[TBL] [Abstract][Full Text] [Related]
4. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
[TBL] [Abstract][Full Text] [Related]
5. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.
Walsh MJ; Vanags DM; Clouston AD; Richardson MM; Purdie DM; Jonsson JR; Powell EE
Hepatology; 2004 May; 39(5):1230-8. PubMed ID: 15122751
[TBL] [Abstract][Full Text] [Related]
6. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
7. Steatosis correlates with hepatic expression of death receptors and activation of nuclear factor-kappaB in chronic hepatitis C.
Hung CH; Lee CM; Kuo FY; Jiang SR; Hu TH; Chen CH; Wang JH; Lu SN; Eng HL; Changchien CS
Liver Int; 2008 Mar; 28(3):339-46. PubMed ID: 18290776
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells.
Pazienza V; Vinciguerra M; Andriulli A; Mangia A
J Gen Virol; 2010 Jul; 91(Pt 7):1678-86. PubMed ID: 20357037
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Archimandritis AJ
Dig Liver Dis; 2007 Oct; 39(10):936-42. PubMed ID: 17720637
[TBL] [Abstract][Full Text] [Related]
11. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
Matos CA; Perez RM; Pacheco MS; Figueiredo-Mendes CG; Lopes-Neto E; Oliveira EB; Lanzoni VP; Silva AE; Ferraz ML
J Gastroenterol Hepatol; 2006 Aug; 21(8):1236-9. PubMed ID: 16872303
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
[TBL] [Abstract][Full Text] [Related]
13. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation.
Abid K; Pazienza V; de Gottardi A; Rubbia-Brandt L; Conne B; Pugnale P; Rossi C; Mangia A; Negro F
J Hepatol; 2005 May; 42(5):744-51. PubMed ID: 15826725
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
[TBL] [Abstract][Full Text] [Related]
15. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C.
Mirandola S; Osterreicher CH; Marcolongo M; Datz C; Aigner E; Schlabrakowski A; Realdon S; Gerotto M; Alberti A; Stickel F
Liver Int; 2009 Apr; 29(4):557-65. PubMed ID: 19018985
[TBL] [Abstract][Full Text] [Related]
16. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Petraki K; Hadziyannis E; Pandelidaki H; Zafiropoulou R; Savvas S; Koskinas J; Archimandritis AJ
Am J Gastroenterol; 2007 Mar; 102(3):634-41. PubMed ID: 17222326
[TBL] [Abstract][Full Text] [Related]
18. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.
Liu CJ; Chen PJ; Jeng YM; Huang WL; Yang WS; Lai MY; Kao JH; Chen DS
J Hepatol; 2005 Aug; 43(2):235-42. PubMed ID: 15964656
[TBL] [Abstract][Full Text] [Related]
19. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.
Zheng L; Lv GC; Sheng J; Yang YD
J Gastroenterol Hepatol; 2010 Jan; 25(1):156-63. PubMed ID: 19780876
[TBL] [Abstract][Full Text] [Related]
20. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]